ETFs
Every Korean-listed ETF: size, money in and out, and how far the price sits from the fund's net asset value.
| Fund | Price | Today | AUM | Flow 1w | Flow 1m | vs NAV |
|---|---|---|---|---|---|---|
| Mighty Biosimilar&CDMO Active0001P0 · Biosimilars · +0.87% | +0.87% | ₩9B | +0.60% |
Closing data for Oct 28, 2026. Flows are new or redeemed shares × NAV. Premium/discount = closing price vs NAV.